Advanced Medical Solutions Given Hold Rating at Numis Securities Ltd (AMS)
Advanced Medical Solutions (LON:AMS)‘s stock had its “hold” rating reiterated by Numis Securities Ltd in a research note issued on Wednesday, American Banking and Market News reports. They currently have a GBX 84 ($1.31) price objective on the stock. Numis Securities Ltd’s price target would suggest a potential downside of 7.69% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Advanced Medical Solutions (LON:AMS) in a research note to investors on Tuesday, September 3rd. They now have a GBX 90 ($1.41) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Advanced Medical Solutions (LON:AMS) in a research note to investors on Tuesday, June 25th. They now have a GBX 77 ($1.20) price target on the stock.
One analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. Advanced Medical Solutions presently has a consensus rating of “Hold” and a consensus target price of GBX 83.20 ($1.30).
Shares of Advanced Medical Solutions (LON:AMS) opened at 90.493 on Wednesday. Advanced Medical Solutions has a 1-year low of GBX 54.00 and a 1-year high of GBX 93.00. The stock’s 50-day moving average is GBX 83.95 and its 200-day moving average is GBX 77.74.
Advanced Medical Solutions Group plc is involved in the design, development, licensing, manufacture and distribution of polymers (LON:AMS) for use in advanced woundcare dressings and materials, and medical adhesives, for closing and sealing tissue.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.